Reports Q1 revenue $984.17M, consensus $941.94M. James C. Foster, Chair, President and Chief Executive Officer, said, “The first quarter demonstrated continued signs of demand stabilization, highlighted by a notable improvement in DSA booking activity to the highest level in two years. This positive development was tempered by the general undertone of uncertainty in the broader market environment, which has led us to a balanced yet cautious view of the remainder of the year. Taking these factors into account, we are modestly increasing our financial guidance for 2025.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CRL:
- Charles River reaches settlement with Elliott, to add 4 directors, Reuters says
- CRL Upcoming Earnings Report: What to Expect?
- Charles River price target raised to $118 from $101 at Baird
- Charles River price target lowered to $150 from $185 at BofA
- Charles River Labs: Hold Rating Amid Uncertain R&D Growth and FDA Policy Impact